title: Hepatitis B reactivation induced by Rituximab maintenance therapy for lymphoma.
authors.forename: Chun-Hung
authors.initials: CH
authors.lastname: Cho
authors.forename: Wen-Lee
authors.initials: WL
authors.lastname: Hwang
authors.forename: Shao-Bin
authors.initials: SB
authors.lastname: Cheng
authors.forename: Teng-Yu
authors.initials: TY
authors.lastname: Lee
authors.forename: Chieh-Lin
authors.initials: CL
authors.lastname: Teng
mesh_terms: D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects* / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D017074:Common Variable Immunodeficiency / Q000139:chemically induced / Q000150:complications; D005260:Female; D006509:Hepatitis B / Q000139:chemically induced* / Q000150:complications / Q000821:virology; D006515:Hepatitis B virus / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D008223:Lymphoma / Q000150:complications / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D000069283:Rituximab; D014775:Virus Activation / Q000187:drug effects*
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab